Bionano Genomics Inc (NAS:BNGO)
$ 0.892 -0.012 (-1.33%) Market Cap: 61.64 Mil Enterprise Value: 47.02 Mil PE Ratio: 0 PB Ratio: 0.62 GF Score: 46/100

Q4 2019 Bionano Genomics Inc Earnings Call Transcript

Mar 05, 2020 / 09:30PM GMT
Release Date Price: $11.3 (+3.67%)
Operator

Greetings. Welcome to the Bionano Genomics Fourth Quarter and Fiscal Year 2019 Conference Call. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to your host, Ashley Robinson from Investor Relations. Please go ahead.

Ashley R. Robinson
LifeSci Advisors, LLC - MD

Thank you, operator, and good afternoon, everyone. Welcome to the Bionano Genomics Fourth Quarter and Year-End 2019 Financial Results Conference Call. Leading the call today will be Dr. Erik Holmlin, CEO of Bionano.

After the market closed today, Bionano issued a press release announcing its financial results for the fourth quarter and year-end 2019. A copy of the release can be found on the Investor Relations page of the company's website.

Before we begin, I would like to remind everyone that certain statements made during this conference call may contain forward-looking statements, including statements about our strategic and commercialization plans, 2020 sales pipeline, anticipated benefits of improvements to the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot